Merck Group appoints head of global procurement

Friedheim Felten takes up role on 1 April

Friedhelm Felten is to become head of corporate procurement, taking over responsibility for the global purchasing activities of the Merck Group.

Taking up the role on 1 April, Felten succeeds Friedrich Schmitt, who has headed the function since 1997 and will be retiring at the end of July. Felten will report to Michael Becker, chief financial officer.

Corporate procurement is responsible for purchasing production materials such as pharmaceutical raw materials and chemicals, and for procuring technical components such as production and laboratory equipment as well as services such as pharmaceutical research and development. The 500 members of the global matrix organisation handle an annual purchasing volume of around b4.5bn.

Felten joined Merck in July 2009 as head of procurement for Services. He has many years of management experience in purchasing and in other functions at international companies, including DHL Global Forwarding in Singapore, DHL Logistics in London, and BASF AG in Ludwigshafen, as well as various BASF subsidiaries in Asia.

You may also like

Finance

Lonza to expand bioscience testing offering with the acquisition of Redberry

Acquisition to include Red One solid-phase cytometry platform for rapid sterility and bioburden testing, which expands Lonza’s portfolio of automated, scalable solutions for pharmaceutical quality control (QC)
Finance

Shilpa Medicare opens flow chemistry manufacturing centre

The flow chemistry centre of excellence includes more than 100 R&D and manufacturing scientists
Finance

Cambrex unveils $120m investment to expand API manufacturing and strengthen US drug supply resilience

Cambrex's continued investments underscore its commitment to adding capabilities and increasing capacity to meet the evolving needs and growing demand of the pharmaceutical industry.
Finance

Curia invests $4m to enhance sterile API manufacturing

The investment aligns with the latest EU GMP Annex 1 standards and reinforces Curia’s longstanding commitment to regulatory excellence and product quality
Finance

Agarose Bead Technologies marks 25 years with $10m global expansion plan

The Spanish agarose resin specialist will expand into the US and India, invest in scalable bioprocessing technologies and enhance sustainability across its European facilities to meet growing demand for advanced therapy purification
Packaging

Sharp Services invests $100m to expand global sterile and packaging capacity across US and Europe

The investment will boost sterile fill/finish, injectable packaging and oral solid dose capacity across Sharp's US and European sites, strengthening its clinical and commercial manufacturing network to meet growing pharmaceutical demand
Finance

MilliporeSigma to acquire JSR Life Sciences’ chromatography business, boosting Protein A purification capabilities

The acquisition expands MilliporeSigma’s downstream bioprocessing portfolio with JSR’s Amsphere Protein A resin technology, enhancing efficiency and reliability in monoclonal antibody and therapeutic protein production
Subscribe now